Mats Axel Atterdag Persson

Title: Innovations of Mats Axel Atterdag Persson

Introduction

Mats Axel Atterdag Persson is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of human monoclonal antibodies. With a total of 2 patents, his work focuses on addressing critical health issues, such as hepatitis C virus (HCV) infections.

Latest Patents

Persson's latest patents include compositions derived from immunoglobulin molecules that are specific for the hepatitis C virus (HCV) E2 antigen. These inventions relate to molecules capable of specifically binding with the HCV E2 antigen. The molecules are designed for use in specific binding assays, affinity purification schemes, and pharmaceutical compositions aimed at preventing and treating HCV infections in mammalian subjects. His inventions encompass novel human monoclonal antibodies specific for HCV E2 antigen, fragments of these antibodies, polypeptides with homologous structures and functions, nucleic acid molecules encoding these polypeptides, and expression vectors containing the nucleic acid molecules.

Career Highlights

Throughout his career, Mats Axel Atterdag Persson has worked with various companies, including Karolina Innovations AB and Karolinska Innovations AB. His expertise in biotechnology has allowed him to contribute to significant advancements in medical research and therapeutic development.

Collaborations

Persson has collaborated with notable professionals in his field, including his coworker Tobias Allander. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Mats Axel Atterdag Persson is a distinguished inventor whose work in developing human monoclonal antibodies has the potential to significantly impact the treatment of hepatitis C virus infections. His contributions to biotechnology continue to pave the way for advancements in medical science.